PMID: 11331612May 2, 2001Paper

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF

Human Molecular Genetics
M A HoffmanW G Kaelin

Abstract

von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germ line mutation of the von Hippel-Lindau tumor suppressor gene (VHL). Tumors observed in this disorder include retinal and central nervous system hemangioblastomas, clear cell renal carcinomas and pheochromocytomas. The VHL gene product, pVHL, is a component of a ubiquitin ligase which targets the transcription factor known as hypoxia-inducible factor (HIF) for degradation in the presence of oxygen. pVHL also plays roles in the control of extracellular matrix formation and cell-cycle exit. Different VHL mutations confer different site-specific risks of cancer. Type 2C VHL mutations confer an increased risk of pheochromocytoma without the other stigmata of VHL disease. Here we report that the products of such type 2C VHL alleles retain the ability to down regulate HIF but are defective for promotion of fibronectin matrix assembly. Furthermore, pVHL L188V, a well studied type 2C mutant, retained the ability to suppress renal carcinoma growth in vivo. These studies strengthen the notion that HIF deregulation plays a causal role in hemangioblastoma and renal carcinoma, and raises the possibility that abnormal fibronectin matrix assembly contributes to pheo...Continue Reading

Citations

May 1, 2008·Journal of Cancer Research and Clinical Oncology·Jin ZhangHanqing Xuan
May 11, 2005·Familial Cancer·Giuseppe OpocherFranco Mantero
Aug 25, 2004·Current Neurology and Neuroscience Reports·Eric W Fitz, Steven A Newman
May 26, 2007·Endocrine Pathology·Aurel Perren, Paul Komminoth
Mar 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·María J Calzada
Nov 30, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wani Arjumand, Sarwat Sultana
May 28, 2004·Trends in Molecular Medicine·Maria F Czyzyk-Krzeska, Jaroslaw Meller
Mar 5, 2003·Journal of the Neurological Sciences·Otto AppenzellerLuciano Bernardi
Aug 15, 2002·Cancer Letters·Deborah Marsh, Roberto Zori
Feb 8, 2003·Current Opinion in Genetics & Development·William Kim, William G Kaelin
Jan 1, 2003·Seminars in Cancer Biology·Christopher William Pugh, Peter John Ratcliffe
Sep 29, 2011·Journal of Proteome Research·Yanlai LaiYuzuru Shiio
Mar 10, 2011·European Journal of Human Genetics : EJHG·Eamonn R MaherStéphane Richard
Jan 4, 2003·Nature Cell Biology·Peter J Ratcliffe
Jan 3, 2003·Nature Cell Biology·Alexander HergovichWilhelm Krek
Mar 3, 2009·Nature Medicine·Yi WangMichael Ohh
Dec 6, 2005·Nature Reviews. Cancer·Eyal Gottlieb, Ian P M Tomlinson
Oct 17, 2008·Nature Reviews. Cancer·William G Kaelin
Jan 26, 2008·Cell Death and Differentiation·P P Kapitsinou, V H Haase
Dec 13, 2005·The New England Journal of Medicine·Herbert T Cohen, Francis J McGovern
Feb 21, 2009·The Journal of Biological Chemistry·Katja KnauthAlexander Buchberger
Feb 1, 2007·Brain : a Journal of Neurology·Emma R WoodwardEamonn R Maher
Aug 21, 2003·Journal of the National Cancer Institute·Jennifer BryantKatherine L Nathanson
Aug 14, 2013·Journal of the National Cancer Institute·Ivana JochmanováKarel Pacak
Dec 20, 2003·Current Opinion in Oncology·Sanziana Roman
Dec 17, 2005·Current Opinion in Oncology·Patricia L M Dahia
Nov 29, 2007·Current Opinion in Oncology·Andrew M Roberts, Michael Ohh
Apr 15, 2004·Genes & Development·Lynne BemisWayne Zundel
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·W G Kaelin
Apr 6, 2011·Annals of Human Genetics·Emanuela LeonardiAlessandra Murgia
Oct 25, 2006·Molecular and Cellular Biology·Andrew J EvansMichael Ohh
Jun 3, 2010·Molecular and Cellular Biology·Anita HsounaTien Hsu
Apr 3, 2004·Molecular and Cellular Biology·Natalie H StickleMichael Ohh
Jun 5, 2008·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Qingzhou Ji, Robert D Burk
Jan 15, 2003·Annual Review of Medicine·Berton ZbarW Marston Linehan
Nov 28, 2007·Annual Review of Pathology·William G Kaelin
Nov 15, 2008·Advances in Urology·José Antonio López-GuerreroJosé Rubio-Briones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.